We are monitoring the impact of COVID-19 & Recession alarm on North America Metabolomics Market Get in touch with us for detailed analysis Know More
Share on

North America Metabolomics Market Research Report - Segmented By Product, Indication, Application & Country (the United States, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecast (2022 to 2027)

Published: January, 2022
ID: 3319
Pages: 175

North America Metabolomics Market Size (2022 to 2027)

The size of the North America Metabolomics Market is valued at USD 497.74 Million in 2022 and is estimated to grow at a CAGR of 18.51% to reach USD 1163.53 Million by 2027.

The key factor contributing to the metabolomics market is government agencies and private actors' massive investment in developing and researching efficient metabolomics. The factors underlying the North American market are the untapped potential of emerging economies and the continuous technological advancements in this area. The metabolomics position s become crucial in the medical field because it allows a deep understanding of diseases' functioning. They also provide protein profiles. Based on applications, the biomarker discovery segment accounted for the majority of the North American metabolomics market.

The increasing prevalence and incidence of chronic diseases such as heart disease, cancer, and diabetes, the growing acceptance of diagnostic cancer tests, and the scientific advancement of discovery technologies are important market growth factors. The increasing adoption of precision medicine has been instrumental in the development of the market. However, the high cost and lack of availability of easy-to-use tools for a straightforward interpretation of data could hamper the growth of the market. Other factors, including rapid urbanization and extensive biotechnology research and development (R&D) activities, are expected to drive the coming years.

The continued growth of high-volume heterogeneous data production increases the data's complexity, and it becomes increasingly difficult to assess all of these data points effectively. Also, due to the chemical diversity of small molecule metabolites, it is not possible to study the entire metabolome using a single analytical technique.

This research report on the North America Metabolomics Market has been segmented and sub-segmented into the following categories:

  • By Product: GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, Surface-based mass analysis
  • By Indication: Oncology, Cardiology, Inborn Error.
  • By Application: Nutrigenomics, Toxicology, Biomarker & Drug Discovery
  • By Country: The United States, Canada & Rest of North America.

Based on the region, North America has the highest share in the Metabolomics market. The USA has the highest demand, followed by Canada and Mexico. Environmental concerns primarily drive the North American area.

Major Companies Operating the North America Metabolomics Market Profiled in the Report are Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.).

1.Introduction

                1.1 Market Definition           

                1.2 Study Deliverables         

                1.3 Base Currency, Base Year and Forecast Periods                 

                1.4 General Study Assumptions       

2. Research Methodology         

                2.1 Introduction                      

                2.2 Research Phases             

       2.2.1 Secondary Research  

       2.2.2 Primary Research                 

       2.2.3 Econometric Modelling                      

       2.2.4 Expert Validation                  

                2.3 Analysis Design                

                2.4 Study Timeline                 

3. Overview     

                3.1 Executive Summary       

                3.2 Key Inferences                

                3.3 Epidemology                     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)  

                4.1 Market Drivers                 

                4.2 Market Restraints           

                4.3 Key Challenges                

                4.4 Current Opportunities in the Market                     

5. Market Segmentation            

                5.1 Product               

       5.1.1 Metabolomic Instruments      

                       5.1.1.1Separation Techniques   

              5.1.1.1.1 Gas Chromatography (GC)

              5.1.1.1.2 Capillary Electrophoresis (CE)

              5.1.1.1.3 High-performance Liquid Chromatography (HPLC)

              5.1.1.1.4 Ultra-performance Liquid Chromatography (UPLC)

                       5.1.1.2 Detection Tools 

              5.1.1.2.1 Mass Spectrometry

              5.1.1.2.2 Nuclear Magnetic Resonance Spectroscopy

              5.1.1.2.3 Surface-Based Mass Analysis

       5.1.2 Metabolomics Bioinformatics Tools and Services                   

                       5.1.2.1 Bioinformatics Tools & Databases              

                       5.1.2.2 Bioinformatics Services  

       5.1.3 Y-o-Y Growth Analysis, By Product      

       5.1.4 Market Attractiveness Analysis, By Product    

       5.1.5 Market Share Analysis, By Product      

                5.2 Indication           

       5.2.1 Cancer                      

       5.2.2 Cardiovascular Disorders                   

       5.2.3 Inborn errors

       5.2.4 Neurological Errors     

       5.2.5 Other Indications                 

       5.2.4 Y-o-Y Growth Analysis, By Indication  

       5.2.5 Market Attractiveness Analysis, By Indication

       5.2.6 Market Share Analysis, By Indication  

                5.3 Application        

       5.3.1 Nutrigenomics                       

       5.3.2 Toxicology      

       5.3.3 Biomarker & Drug Discovery   

       5.3.4 Functional Genomics 

       5.3.5 Personalized Medicine                      

       5.3.6 Other Applications

       5.3.7 Y-o-Y Growth Analysis, By Application

       5.3.8 Market Attractiveness Analysis, By Application                       

       5.3.9  Market Share Analysis, By Application                       

6. Geographical Analysis            

                6.1 Introduction                      

       6.1.1 Regional Trends                    

       6.1.2 Impact Analysis                     

       6.1.3 Y-o-Y Growth Analysis                        

                       6.1.3.1 By Geographical Area     

                       6.1.3.2 By Product           

                       6.1.3.3 By Indication       

       6.1.4 Market Attractiveness Analysis                      

                       6.1.4.1 By Geographical Area     

                       6.1.4.2 By Product           

                       6.1.4.3 By Indication       

       6.1.5 Market Share Analysis                       

                       6.1.5.1 By Geographical Area     

                       6.1.5.2 By Product           

                       6.1.5.3 By Indication       

                6.2 United States                   

                6.3 Canada                

7.Strategic Analysis      

                7.1 PESTLE analysis                

       7.1.1 Political                     

       7.1.2 Economic                 

       7.1.3 Social

       7.1.4 Technological

       7.1.5 Legal 

       7.1.6 Environmental                       

                7.2 Porter’s Five analysis                     

       7.2.1 Bargaining Power of Suppliers                        

       7.2.2 Bargaining Power of Consumers                    

       7.2.3 Threat of New Entrants                     

       7.2.4 Threat of Substitute Products and Services     

       7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis       

                8.1 Waters Corporation (U.S.)          

       8.1.1 Overview                 

       8.1.2 Product Analysis                   

       8.1.3 Financial analysis                  

       8.1.4 Recent Developments                       

       8.1.5 SWOT analysis                       

       8.1.6 Analyst View 

                8.2 Agilent Technologies, Inc. (U.S.)               

                8.3 Human Metabolome Technologies, Inc. (Japan)               

                8.4 Thermo Fisher Scientific, Inc. (U.S.)        

                8.5 LECO Corporation (U.S.)               

                8.6 Bruker Corporation (U.S.)           

                8.7 Shimadzu Corporation (Japan)                  

                8.8 Metabolon Inc. (U.S.)                   

                8.9 Danaher Corporation (U.S.)        

                8.10 Biocrates Life Sciences AG (Austria)                     

9.Competitive Landscape          

                9.1 Market share analysis                   

                9.2 Merger and Acquisition Analysis              

                9.3 Agreements, collaborations and Joint Ventures                

                9.4 New Product Launches                

10.Market Outlook and Investment Opportunities        

Appendix         

                a) List of Tables       

                b) List of Figures                     

  1. North America Metabolomics Market, By Product, From 2022 - 2027 (USD Billion)
  2. North America GC Market, By Region, From 2022 - 2027 (USD Billion)
  3. North America Bioinformatics Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Mass Spectroscopy Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America HPLC Market, By Region, From 2022 - 2027 (USD Billion)
  6. North America UPLC Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America NMRS Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America Surface Based analysis Market, By Region, From 2022 - 2027 (USD Billion)
  9. North America Metabolomics Market, By Indication, From 2022 - 2027 (USD Billion)
  10. North America Oncology Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America Cardiology Market, By Region, From 2022 - 2027 (USD Billion)
  12. North America Inborn Errors Market, By Region, From 2022 - 2027 (USD Billion)
  13. North America Metabolomics Market, By Application, From 2022 - 2027 (USD Billion)
  14. North America Nutrigenomics Market, By Region, From 2022 - 2027 (USD Billion)
  15. North America Toxicology Market, By Region, From 2022 - 2027 (USD Billion)
  16. North America Biomarker & Drug Discovery Market, By Region, From 2022 - 2027 (USD Billion)
  17. United States Metabolomics Market, By Product, From 2022 - 2027 (USD Billion)
  18. United States Metabolomics Market, By Indication, From 2022 - 2027 (USD Billion)
  19. United States Metabolomics Market, By Application, From 2022 - 2027 (USD Billion)
  20. Canada Metabolomics Market, By Product, From 2022 - 2027 (USD Billion)
  21. Canada Metabolomics Market, By Indication, From 2022 - 2027 (USD Billion)
  22. Canada Metabolomics Market, By Application, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample